Contribution of RIP3 and MLKL to immunogenic cell death signaling in cancer chemotherapy.
about
Reestablishment of p53/Arf and interferon-β pathways mediated by a novel adenoviral vector potentiates antiviral response and immunogenic cell death.Inhibition of Aurora Kinase A Induces Necroptosis in Pancreatic Carcinoma.The immune contexture in cancer prognosis and treatment.Uncovering the immunotherapeutic cycle initiated by p19Arf and interferon-β gene transfer to cancer cells: An inducer of immunogenic cell death.Harnessing combined p19Arf and interferon-beta gene transfer as an inducer of immunogenic cell death and mediator of cancer immunotherapy.Necroptosis: Mechanisms and Relevance to Disease.Immunomodulatory and antitumor effects of type I interferons and their application in cancer therapy.Pro-necrotic molecules impact local immunosurveillance in human breast cancer.Cell death and immunity in cancer: From danger signals to mimicry of pathogen defense responses.Necroptotic cell death in anti-cancer therapy.Wilms tumour 1 peptide vaccine as a cure-oriented post-chemotherapy strategy for patients with acute myeloid leukaemia at high risk of relapse.The renaissance of anti-neoplastic immunity from tumor cell demise.Extracellular nucleosides and nucleotides as immunomodulators.TFAM is a novel mediator of immunogenic cancer cell death.Multi-faceted immunomodulatory and tissue-tropic clinical bacterial isolate potentiates prostate cancer immunotherapy.BNIP3 modulates the interface between B16-F10 melanoma cells and immune cells.Trial watch: Immunogenic cell death induction by anticancer chemotherapeuticsIdentification of the predictive genes for the response of colorectal cancer patients to FOLFOX therapyTumGrowth: An open-access web tool for the statistical analysis of tumor growth curvesOncolysis with DTT-205 and DTT-304 generates immunological memory in cured animalsPattern Recognition Receptors and the Host Cell Death Molecular Machinery
P2860
Q37710422-11263B2A-45DD-4304-905A-30EF6102E4C2Q38695950-45CB27F4-4F71-4736-83A0-5E3BD7AAD73AQ39456999-09530123-8076-4450-A6CD-253B0CDFE16CQ40081800-D1F08264-9C68-4E45-A262-9C2200738CEDQ40206389-A985CD89-85FC-44C3-BC79-1DD95B0A73AAQ40411907-68B1CF5F-0F72-4C21-BFAA-625532A9EED1Q42378527-689A5D28-ABD8-43A4-820E-C9B64FF2C991Q42509779-DF2331E2-B045-4654-9B9A-5B804727EE66Q47614555-375F0360-1C85-426E-A84F-4B3C278D16B8Q47659073-37FF4767-38EB-474B-B51E-45DEE7CE76B0Q47881261-349ECBBD-7146-495F-849B-DC307820920AQ48193643-C3ACA22A-40BE-4CD5-A448-BE3E87073CF4Q48193659-86839A39-76DE-456F-99FD-6FDCA37FD0CAQ54942963-CE75246B-066D-462A-A942-83DAEF3BBBCAQ55156621-264775C0-3C54-49A8-8EF6-8AF205BE9714Q55512760-779A62F9-78DD-4974-B495-B2711119E639Q56594845-AC0FA38C-B72E-4780-A900-A76A555A1783Q57074537-37A29C49-E36D-4DF8-93A8-7F880BD60B91Q57082682-E79B82A4-CE88-452E-BFAC-775092FF84D9Q57796314-1A4D5259-A021-4C32-A37E-D5A953F32DEEQ59136362-ACE19193-A4FC-4968-AE3E-BB02F3DAED85
P2860
Contribution of RIP3 and MLKL to immunogenic cell death signaling in cancer chemotherapy.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 10 March 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Contribution of RIP3 and MLKL to immunogenic cell death signaling in cancer chemotherapy.
@en
Contribution of RIP3 and MLKL to immunogenic cell death signaling in cancer chemotherapy.
@nl
type
label
Contribution of RIP3 and MLKL to immunogenic cell death signaling in cancer chemotherapy.
@en
Contribution of RIP3 and MLKL to immunogenic cell death signaling in cancer chemotherapy.
@nl
prefLabel
Contribution of RIP3 and MLKL to immunogenic cell death signaling in cancer chemotherapy.
@en
Contribution of RIP3 and MLKL to immunogenic cell death signaling in cancer chemotherapy.
@nl
P2093
P2860
P50
P1433
P1476
Contribution of RIP3 and MLKL to immunogenic cell death signaling in cancer chemotherapy.
@en
P2093
Allan Sauvat
Christophe Klein
Federico Pietrocola
Sylvie Souquere
P2860
P304
P356
10.1080/2162402X.2016.1149673
P577
2016-03-10T00:00:00Z